KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
2021 · The Lancet · 721 citations
https://doi.org/10.1016/s0140-6736(21)01222-8
M
Maria R. Baer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
900
Papers
23.4K
Citations
73
h-index
293
i10-index
Maria R. Baer is an academic researcher from Northwestern University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Acute Lymphoblastic Leukemia research. The author has an h-index of 73, co-authored 765 publications.
ORCID: 0000-0002-9499-1348Papers by this author
worksFLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
2010 · Blood · 230 citations
https://doi.org/10.1182/blood-2010-05-283648
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
2022 · The Lancet Haematology · 111 citations
https://doi.org/10.1016/s2352-3026(22)00292-7
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
2014 · Leukemia · 73 citations
https://doi.org/10.1038/leu.2014.267
The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations
2015 · Investigational New Drugs · 28 citations
https://doi.org/10.1007/s10637-015-0205-y
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
2014 · Oncology Reports · 26 citations
https://doi.org/10.3892/or.2014.3002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat